Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients
NCT00481923
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
156
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
rimonabant (SR141716)
Sponsor
Sanofi